Related references
Note: Only part of the references are listed.Recent developments and current concepts in medulloblastoma
N. U. Gerber et al.
CANCER TREATMENT REVIEWS (2014)
Are pediatric brain tumors on the rise in the USA? Significant incidence and survival findings from the SEER database analysis
Swetal Patel et al.
CHILDS NERVOUS SYSTEM (2014)
MicroRNA-34a regulates cardiac ageing and function
Reinier A. Boon et al.
NATURE (2013)
The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma
Kristian W. Pajtler et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma
Alfa H. C. Bai et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Pleiotropic effects of miR-183∼96∼182 converge to regulate cell survival, proliferation and migration in medulloblastoma
Shyamal Dilhan Weeraratne et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression
Jan J. Molenaar et al.
NATURE GENETICS (2012)
Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas
Annette Kuenkele et al.
NEURO-ONCOLOGY (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Intact p53-Dependent Responses in miR-34-Deficient Mice
Carla P. Concepcion et al.
PLOS GENETICS (2012)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
miR-34 miRNAs provide a barrier for somatic cell reprogramming
Yong Jin Choi et al.
NATURE CELL BIOLOGY (2011)
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Shyamal D. Weeraratne et al.
NEURO-ONCOLOGY (2011)
MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15+/CD133+ Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma
Pasqualino de Antonellis et al.
PLOS ONE (2011)
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
Fadila Guessous et al.
CELL CYCLE (2010)
Pleiotropic role for MYCN in medulloblastoma
Fredrik J. Swartling et al.
GENES & DEVELOPMENT (2010)
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells
Na Li et al.
CANCER LETTERS (2009)
The miR-17/92 Polycistron Is Up-regulated in Sonic Hedgehog-Driven Medulloblastomas and Induced by N-myc in Sonic Hedgehog-Treated Cerebellar Neural Precursors
Paul A. Northcott et al.
CANCER RESEARCH (2009)
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer
Elena Gallardo et al.
CARCINOGENESIS (2009)
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Barbara Stecca et al.
EMBO JOURNAL (2009)
Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness
F. Cimmino et al.
ONCOGENE (2009)
The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma
Tamar Uziel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Yasunori Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Medulloblastoma can be initiated by deletion of patched in lineage-restricted progenitors or stem cells
Zeng-Jie Yang et al.
CANCER CELL (2008)
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Dmitri Lodygin et al.
CELL CYCLE (2008)
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene
Kristina A. Cole et al.
MOLECULAR CANCER RESEARCH (2008)
The MYCN oncogene is a direct target of miR-34a
J. S. Wei et al.
ONCOGENE (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Guido T. Bommer et al.
CURRENT BIOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells
C. Welch et al.
ONCOGENE (2007)
Differential regulation of microRNAs by p53 revealed by massively parallel Sequencing -: miR-34a is a p53 target that induces apoptosis and G1-arrest
Valery Tarasov et al.
CELL CYCLE (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Tsung-Cheng Chang et al.
MOLECULAR CELL (2007)
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis
Nina Raver-Shapira et al.
MOLECULAR CELL (2007)
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
William R. Polkinghorn et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth
Beryl A. Hatton et al.
CANCER RESEARCH (2006)
N-Myc and the cyclin-dependent kinase inhibitors p18Ink4c and P27Kip1 coordinately regulate cerebellar development
Frederique Zindy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MicroRNA-cancer connection: The beginning of a new tale
George Adrian Calin et al.
CANCER RESEARCH (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
MicroRNAs in cell proliferation, cell death, and tumorigenesis
HW Hwang et al.
BRITISH JOURNAL OF CANCER (2006)
N-myc can substitute for insulin-like growth factor signalling in a mouse mode of sonic hedgehog-induced medulloblastoma
SR Browd et al.
CANCER RESEARCH (2006)
The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma
Tamar Uziel et al.
CELL CYCLE (2006)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Isolation of neural stem cells from the postnatal cerebellum
A Lee et al.
NATURE NEUROSCIENCE (2005)
Introducing the German Mouse Clinic:: open access platform for standardized phenotyping
V Gailus-Durner et al.
NATURE METHODS (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma
A Slack et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas
AR Hallahan et al.
CANCER RESEARCH (2004)
Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival
K Neben et al.
CANCER RESEARCH (2004)
MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
V Ambros
CELL (2003)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation
PS Knoepfler et al.
GENES & DEVELOPMENT (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
Share Paper
